facebook twitter linkedin instagram youtube spotify
×
<
>
loading_icra
Home Credit Perspective Reports Naari Pharma Pvt. Ltd.
bg-rating-rationales

Entity-Specific Rating Rationales

21 Mar 2025

Naari Pharma Pvt. Ltd.: Ratings withdrawn

Naari Pharma Pvt. Ltd.: Ratings withdrawn

icon-download
bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

14 May 2020

Naari Pharma Pvt. Ltd.

Naari Pharma Pvt. Ltd. (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Term Loan -- -- Withdrawn --
Working Capital Limits -- -- Withdrawn --
Fund-based/ Non-fund based – Working capital limits (sublimit) Withdrawn -- -- --

Our Analysts

Analyst 1

Pavethra Ponniah

Analyst 2

Mythri Macherla

Sector Head

Subrata Ray
bg-rating-research

Most Trending Research Reports

icon-prime

icon-download icon-download icon-sbscribe icon-sbscribe

View More
bg-rating-rationales

Rating Rationales
icon-download

View More
Upcoming Webinars
Presentations And Recordings

Coming Soon...

View More
08 Apr 2025 04:00 PM

ICRA Webinar on the Indian Banking Sector - Regulatory easing to support credit growth in FY2026; asset quality remains monitorable

--By Mr Karthik Srinivasan,Mr Anil Gupta,Mr Sachin Sachdeva
PPT
03 Apr 2025 04:00 PM

ICRA Webinar on Outlook FY2026

--By Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Karthik Srinivasan
PPT
View More

Podcast


ICRA Podcast on Banking Sector Outlook FY2026 | Insights by Sachin Sachdeva

Apr 2025

View More

Media Release



View More
banner-ask-expert
Ask Our Industry Analyst
Get in touch with our Business Representative
You can show error msg here
(*Denotes Compulsory field)

Submit